Clinical Trial Update: Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects

View source ↗

Summary

A clinical trial update examines whether DPP-4 inhibition influences inflammatory parameters in people with type 2 diabetes, with analysis by gender.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Risk
• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Medical University of Vienna | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Risk | Status: UNKNOWN